Genome engineering using site-specific recombinases

    Research output: Contribution to journalArticle

    36 Citations (Scopus)

    Abstract

    The targeted modification of the mammalian genome has a variety of applications in research, medicine, and biotechnology. Site-specific recombinases have become significant tools in all of these areas. Conditional gene targeting using site-specific recombinases has enabled the functional analysis of genes, which cannot be inactivated in the germline. The site-specific integration of adeno-associated virus, a major gene therapy vehicle, relies on the recombinase activity of the viral rep proteins. Site-specific recombinases also allow the precise integration of open reading frames encoding pharmaceutically relevant proteins into highly active gene loci in cell lines and transgenic animals. These goals have been accomplished by using a variety of genetic strategies but only a few recombinase proteins. However, the vast repertoire of recombinases, which has recently become available as a result of large-scale sequencing projects, may provide a rich source for the development of novel strategies to precisely alter mammalian genomes.
    Original languageEnglish
    Pages (from-to)65-80
    Number of pages16
    JournalCloning and Stem Cells
    Volume4
    Issue number1
    DOIs
    Publication statusPublished - 1 Jan 2002

    Fingerprint

    Recombinases
    Genome
    Dependovirus
    Genetically Modified Animals
    Gene Targeting
    Viral Proteins
    Biotechnology
    Genetic Therapy
    Open Reading Frames
    Genes
    Proteins
    Medicine
    Cell Line
    Research
    Site-specific recombinase

    Keywords

    • Animals
    • Animals, Genetically Modified
    • DNA
    • DNA Nucleotidyltransferases
    • Dependovirus
    • Genetic Engineering
    • Genetic Techniques
    • Genetic Vectors
    • Humans
    • Mice
    • Models, Genetic
    • Mutagenesis, Site-Directed
    • Open Reading Frames
    • Recombinases

    Cite this

    Genome engineering using site-specific recombinases. / Kolb, Andreas.

    In: Cloning and Stem Cells, Vol. 4, No. 1, 01.01.2002, p. 65-80.

    Research output: Contribution to journalArticle

    @article{cab0bd3e007f4a329e232e4015012a0a,
    title = "Genome engineering using site-specific recombinases",
    abstract = "The targeted modification of the mammalian genome has a variety of applications in research, medicine, and biotechnology. Site-specific recombinases have become significant tools in all of these areas. Conditional gene targeting using site-specific recombinases has enabled the functional analysis of genes, which cannot be inactivated in the germline. The site-specific integration of adeno-associated virus, a major gene therapy vehicle, relies on the recombinase activity of the viral rep proteins. Site-specific recombinases also allow the precise integration of open reading frames encoding pharmaceutically relevant proteins into highly active gene loci in cell lines and transgenic animals. These goals have been accomplished by using a variety of genetic strategies but only a few recombinase proteins. However, the vast repertoire of recombinases, which has recently become available as a result of large-scale sequencing projects, may provide a rich source for the development of novel strategies to precisely alter mammalian genomes.",
    keywords = "Animals, Animals, Genetically Modified, DNA, DNA Nucleotidyltransferases, Dependovirus, Genetic Engineering, Genetic Techniques, Genetic Vectors, Humans, Mice, Models, Genetic, Mutagenesis, Site-Directed, Open Reading Frames, Recombinases",
    author = "Andreas Kolb",
    year = "2002",
    month = "1",
    day = "1",
    doi = "10.1089/153623002753632066",
    language = "English",
    volume = "4",
    pages = "65--80",
    journal = "Cloning and Stem Cells",
    issn = "1536-2302",
    publisher = "Mary Ann Liebert Inc.",
    number = "1",

    }

    TY - JOUR

    T1 - Genome engineering using site-specific recombinases

    AU - Kolb, Andreas

    PY - 2002/1/1

    Y1 - 2002/1/1

    N2 - The targeted modification of the mammalian genome has a variety of applications in research, medicine, and biotechnology. Site-specific recombinases have become significant tools in all of these areas. Conditional gene targeting using site-specific recombinases has enabled the functional analysis of genes, which cannot be inactivated in the germline. The site-specific integration of adeno-associated virus, a major gene therapy vehicle, relies on the recombinase activity of the viral rep proteins. Site-specific recombinases also allow the precise integration of open reading frames encoding pharmaceutically relevant proteins into highly active gene loci in cell lines and transgenic animals. These goals have been accomplished by using a variety of genetic strategies but only a few recombinase proteins. However, the vast repertoire of recombinases, which has recently become available as a result of large-scale sequencing projects, may provide a rich source for the development of novel strategies to precisely alter mammalian genomes.

    AB - The targeted modification of the mammalian genome has a variety of applications in research, medicine, and biotechnology. Site-specific recombinases have become significant tools in all of these areas. Conditional gene targeting using site-specific recombinases has enabled the functional analysis of genes, which cannot be inactivated in the germline. The site-specific integration of adeno-associated virus, a major gene therapy vehicle, relies on the recombinase activity of the viral rep proteins. Site-specific recombinases also allow the precise integration of open reading frames encoding pharmaceutically relevant proteins into highly active gene loci in cell lines and transgenic animals. These goals have been accomplished by using a variety of genetic strategies but only a few recombinase proteins. However, the vast repertoire of recombinases, which has recently become available as a result of large-scale sequencing projects, may provide a rich source for the development of novel strategies to precisely alter mammalian genomes.

    KW - Animals

    KW - Animals, Genetically Modified

    KW - DNA

    KW - DNA Nucleotidyltransferases

    KW - Dependovirus

    KW - Genetic Engineering

    KW - Genetic Techniques

    KW - Genetic Vectors

    KW - Humans

    KW - Mice

    KW - Models, Genetic

    KW - Mutagenesis, Site-Directed

    KW - Open Reading Frames

    KW - Recombinases

    U2 - 10.1089/153623002753632066

    DO - 10.1089/153623002753632066

    M3 - Article

    VL - 4

    SP - 65

    EP - 80

    JO - Cloning and Stem Cells

    JF - Cloning and Stem Cells

    SN - 1536-2302

    IS - 1

    ER -